Perceptive Discovery and Nucleus RadioPharma have announced a non-exclusive strategic partnership to assist radiopharmaceutical developers shift from initial target validation through…
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Urolution Medical’s OpenFlo urinary catheter. Cleared for adult use, the device drains the urinary tract and can remain…
Perceive Biotherapeutics (Perceive Bio) has concluded enrolment ahead of targets in its Phase IIa JOURNEY clinical study evaluating VOY-101, an experimental gene therapy for geographic atrophy (GA) caused by dry…
US-based medical device company SurGenTec has entered into an exclusive licence agreement with Allevion Medical to acquire the rights to the Vantage spinal decompression system. The patented technology provides a…
Viome Life Sciences’ clinical division Viome PRO has launched CancerDetect Pancreatic, a physician-ordered blood test designed to identify pancreatic ductal adenocarcinoma. The assay assesses the enzymatic activity tumours to break…
Alpheus Medical has begun the multi-centre Butterfly study to assess its investigational Porphyrin Metabolite Activation (PoMA) therapy in patients with butterfly glioblastoma (GBM). The study aims to evaluate the safety…
Biohaven has entered into an exclusive regional collaboration and licensing agreement worth up to $100m with Ono Pharmaceutical for its MoDE pan immunoglobulin G (IgG) degrader portfolio. The transaction grants…
